Year archive

Vaxcell-Bio Therapeutics — 2022 filings

All 22 regulatory filings released by Vaxcell-Bio Therapeutics (323990) in 2022, sourced directly from the official regulator.

22 Filings

2022 Period

2022 filings (22)

Filing	Released	Lang
주주명부폐쇄기간또는기준일설정 Regulatory Filings	2022-12-15	Korean
분기보고서 (2022.09) Interim / Quarterly Report 9M 2022	2022-11-14	Korean
기업설명회(IR)개최 Report Publication Announcement	2022-09-02	Korean
투자판단관련주요경영사항(Vax-DC 2a/b상 임상시험 연구개발 조기종료의 건) Legal Proceedings Report	2022-08-24	Korean
반기보고서 (2022.06) Interim / Quarterly Report H1 2022	2022-08-16	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2022-07-15	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2022-07-15	Korean
[기재정정]사업보고서 (2021.12) Annual Report FY 2021	2022-07-05	Korean
기업설명회(IR)개최 Report Publication Announcement	2022-06-03	Korean
분기보고서 (2022.03) Interim / Quarterly Report Q1 2022	2022-05-16	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2022-04-18	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2022-04-11	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2022-04-05	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2022-03-23	Korean
사업보고서 (2021.12) Audit Report / Information FY 2021	2022-03-15	Korean
감사보고서제출 Audit Report / Information FY 2021	2022-03-11	Korean
주주총회소집결의 AGM Information	2022-03-08	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2022-03-08	Korean
기업설명회(IR)개최 Report Publication Announcement	2022-02-15	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2021	2022-02-07	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2022-02-07	Korean
대표이사변경 Board/Management Information	2022-01-10	Korean